Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy.
Rafei-Shamsabadi D, Scholten L, Lu S, Castiglia D, Zambruno G, Volz A, Arnold A, Saleva M, Martin L, Technau-Hafsi K, Meiss F, von Bubnoff D, Has C. Rafei-Shamsabadi D, et al. Among authors: meiss f. Cancers (Basel). 2024 Jan 22;16(2):471. doi: 10.3390/cancers16020471. Cancers (Basel). 2024. PMID: 38275911 Free PMC article.
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
Dalle S, Mortier L, Corrie P, Lotem M, Board R, Arance AM, Meiss F, Terheyden P, Gutzmer R, Buysse B, Oh K, Brokaw J, Le TK, Mathias SD, Scotto J, Lord-Bessen J, Moshyk A, Kotapati S, Middleton MR. Dalle S, et al. Among authors: meiss f. BMC Cancer. 2021 May 29;21(1):642. doi: 10.1186/s12885-021-08032-y. BMC Cancer. 2021. PMID: 34051732 Free PMC article. Clinical Trial.
Vemurafenib and ipilimumab: A promising combination? Results of a case series.
Hassel JC, Lee SB, Meiss F, Meier F, Dimitrakopoulou-Strauss A, Jäger D, Enk AH. Hassel JC, et al. Among authors: meiss f. Oncoimmunology. 2015 Oct 29;5(4):e1101207. doi: 10.1080/2162402X.2015.1101207. eCollection 2016 Apr. Oncoimmunology. 2015. PMID: 27141385 Free PMC article.
[First network meeting of the certified skin tumor centers].
Eigentler TK, Utikal J, Huber MA, Meiss F, Schneider LA. Eigentler TK, et al. Among authors: meiss f. J Dtsch Dermatol Ges. 2015 Aug;13(8):847-8. doi: 10.1111/ddg.12762. J Dtsch Dermatol Ges. 2015. PMID: 26213830 German. No abstract available.
Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression.
Andrlová H, Mastroianni J, Madl J, Kern JS, Melchinger W, Dierbach H, Wernet F, Follo M, Technau-Hafsi K, Has C, Rao Mittapalli V, Idzko M, Herr R, Brummer T, Ungefroren H, Busch H, Boerries M, Narr A, Ihorst G, Vennin C, Schmitt-Graeff A, Minguet S, Timpson P, Duyster J, Meiss F, Römer W, Zeiser R. Andrlová H, et al. Among authors: meiss f. Oncotarget. 2017 Jun 27;8(26):42901-42916. doi: 10.18632/oncotarget.17160. Oncotarget. 2017. PMID: 28476030 Free PMC article.
Papulopustular lesions of the face and scalp.
Wessbecher R, Technau-Hafsi K, Meiss F, Schauer F. Wessbecher R, et al. Among authors: meiss f. J Dtsch Dermatol Ges. 2017 Jul;15(7):755-757. doi: 10.1111/ddg.13265. Epub 2017 Jun 14. J Dtsch Dermatol Ges. 2017. PMID: 28612972 No abstract available.
Papulopustulose des Gesichts und des Capillitiums.
Wessbecher R, Technau-Hafsi K, Meiss F, Schauer F. Wessbecher R, et al. Among authors: meiss f. J Dtsch Dermatol Ges. 2017 Jul;15(7):755-757. doi: 10.1111/ddg.13265_g. J Dtsch Dermatol Ges. 2017. PMID: 28677191 No abstract available.
131 results